HPV Vaccine Jeopardizes Girls’ Health ?
HPV Vaccine Jeopardizes Girls’ Health ?

A vaccine conceived in order to prevent cervical cancer is due to be thoroughly analyzed as a result of thousands of reports which associated it to a variety of health disorders.

According to the Centers for Disease Control and Prevention, Merck & Co. Inc.’s Gardasil has been the topic of over 7,800 “adverse event” complaints since the Food and Drug Administration endorsed its employ two years ago.

Girls and women have held the vaccine accountable for producing illnesses varying from nausea to paralysis or even death. The FDA received fifteen death reports, out of which 10 cases were authenticated. However, the Centers for Disease Control says none of the occurrences were connected to the vaccine. Furthermore, the CDC informed that it maintains revising the reports of ailments.

The vaccine ceases the extension of human papillomavirus, also known as HPV, a sexually spread virus that can produce cervical cancer in a rather small number of girls and women.

Gardasil’s manufacturer, Merck & Co. Inc., declares that it has distributed approximately 26 million vaccines in the whole world, taking account of the almost 16 million sales in the United States. Moreover, the company reckons that since June 2006 at least 8 million girls and women have had the vaccine in the United States.

Two of the supposed Gardasil victims took the vaccine’s producer to court. According to CNN, one of the girls, Jesalee Parsons of Broken Bow, Oklahoma, was vaccinated against HPV at the age of 13. Soon after receiving the shot, the girl developed a fever and felt an acute pain in her chest and abdomen, as said by Michael McLaren, Jesalee Parsons’ lawyer.

Merck & Co. Inc. responded to the accusations by stating that the sudden sickness of the teenager could have been a simple coincidence. The company said it would continue to assess complaints of adverse effects and that product labels would be added “new safety information as appropriate.”




© 2007 - 2009 - eNews 2.0 All Rights Reserved
 
 
 
 



 

dotclear
dotclear